Emily K. Yeung

Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Efficacy and safety of canagliflozin are consistent across polypharmacy burden in CKD: the CREDENCE trial.

Effects of SGLT2 inhibition on insulin use in CKD and type 2 diabetes: insights from the CREDENCE trial.

Combination therapy as a new standard of care in diabetic and non-diabetic chronic kidney disease.

A global overview of health system financing and available infrastructure and oversight for kidney care.

Perioperative management of patients with neuroendocrine tumours.

Showing 1-12 of 20

Last Updated: 09/26/2026